Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004
Published online before print July 1, 2004, doi: 10.1161/01.RES.0000137727.34938.35
A more recent version of this article appeared on August 6, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
95/3/325    most recent
01.RES.0000137727.34938.35v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diaz, R. J.
Right arrow Articles by Wilson, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diaz, R. J.
Right arrow Articles by Wilson, G. J.
Related Collections
Right arrow Ischemic biology - basic studies
Right arrow Ion channels/membrane transport

Submitted on December 11, 2003
Revised on June 16, 2004
Accepted on June 17, 2004

Selective Inhibition of Inward Rectifier K+ Channels (Kir2.1 or Kir2.2) Abolishes Protection by Ischemic Preconditioning in Rabbit Ventricular Cardiomyocytes

Roberto J. Diaz ; Carsten Zobel ; Hee Cheol Cho ; Michelle Batthish ; Alina Hinek ; Peter H. Backx ; and Gregory J. Wilson *

From the Divisions of Cardiovascular Research (R.J.D., M.B., A.H., G.J.W.) and Pathology (G.J.W.), Research Institute, The Hospital for Sick Children; the Departments of Physiology (H.C.C., M.B., P.H.B., G.J.W.) and Medicine (P.H.B.), The University of Toronto; and the Division of Cardiology (C. Z., P.H.B.), University Health Network, Toronto, Canada. Present address of C.Z. is Laboratory of Muscle Research and Molecular Cardiology, Clinic III for Internal Medicine, University of Cologne, Cologne, Germany.

* To whom correspondence should be addressed. E-mail: Diazport{at}sickkids.ca.

Volume regulatory Cl- channels are key regulators of ischemic preconditioning (IPC). Because Cl- efflux must be balanced by an efflux of cations to maintain cell membrane electroneutrality during volume regulation, we hypothesize that IK1 channels may play a role in IPC. We subjected cultured cardiomyocytes to 60-minute simulated ischemia (SI) followed by 60-minute of simulated reperfusion (SR) and assessed percent cell death using trypan blue staining. Ischemic preconditioning (10-minute SI/10-minute SR) significantly (P<0.0001) reduced the percent cell death in nontransfected cardiomyocytes [IPCCM 18.0±2.1% versus control (CCM) 48.3±1.0%]. IPC protection was not altered by overexpression of the reporter gene (enhanced green fluorescent protein, EGFP). However, overexpression of dominant-negative Kir2.1 or Kir2.2 genes using adenoviruses (AdEGFPKir2.1DN or AdEGFPKir2.2DN) encoding the reporter gene EGFP prevented IPC protection [both IPCCM+AdEGFPKir2.1DN 45.8±2.3% (mean±SEM) and IPCCM+AdEGFPKir2.2DN 47.9±1.4% versus IPCCM; P<0.0001] in cultured cardiomyocytes (n=8 hearts). Transfection of cardiomyocytes with AdEGFPKir2.1DN or AdEGFPKir2.2DN did not affect cell death in control (nonpreconditioned) cardiomyocytes (both CCM+ AdEGFPKir2.1DN 45.8±0.7% and CCM+AdEGFPKir2.2DN 46.2±1.3% versus CCM; not statistically significant). Similar effects were observed in both cultured (n=5 hearts) and freshly isolated (n=4 hearts) ventricular cardiomyocytes after IK1 blockade with 20 µmol/L BaCl2 plus 1 µmol/L nifedipine (to prevent Ba2+ uptake). Nifedipine alone neither protected against ischemic injury nor blocked IPC protection. Our findings establish that IK1 channels play an important role in IPC protection.


Key words: ischemic preconditioning • cardiomyocytes • ischemia • potassium channels • gene transfer




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y. Lu, Y. Zhang, H. Shan, Z. Pan, X. Li, B. Li, C. Xu, B. Zhang, F. Zhang, D. Dong, et al.
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection
Cardiovasc Res, July 31, 2009; (2009) cvp232v2.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J.-F. Chen, T. E. Callis, and D.-Z. Wang
microRNAs and muscle disorders
J. Cell Sci., January 1, 2009; 122(1): 13 - 20.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. Yang, Y. Lu, and Z. Wang
Control of cardiac excitability by microRNAs
Cardiovasc Res, September 1, 2008; 79(4): 571 - 580.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Zhang, N. Honbo, E. J. Goetzl, K. Chatterjee, J. S. Karliner, and M. O. Gray
Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3150 - H3158.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Z.-Z. Mei, H.-J. Mao, and L.-H. Jiang
Conserved cysteine residues in the pore region are obligatory for human TRPM2 channel function
Am J Physiol Cell Physiol, November 1, 2006; 291(5): C1022 - C1028.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. J. Diaz and G. J. Wilson
Studying ischemic preconditioning in isolated cardiomyocyte models
Cardiovasc Res, May 1, 2006; 70(2): 286 - 296.
[Abstract] [Full Text] [PDF]